drugset / Trial / NCT06046105

Efficacy of Adding Dexmedetomidine Versus Ibuprofen as an Adjuvant to Intraperitoneal Bupivacaine for Pain Control After Laparoscopic Gynecological Procedures

NCT06046105

Phase 2/3 Unknown 180 enrolled Ain Shams University
RandomizedParallel-groupDouble-blindTreatment

Summary

The goal of this clinical trial is to compare the analgesic efficacy of adding dexmedetomidine versus ibuprofen to bupivacaine for intraperitoneal instillation after laparoscopic gynecological procedures. The main questions to answer are: * Which is more effective for controlling postoperative pain within the first 24 hours after the procedure? * Which is more convenient for the patients with fewer side effects and opioid consumption? Participants will be asked to assess * The postoperative pain severity by VAS score * The onset of the first analgesic request * The incidence of side effects like nausea and vomiting Researchers will compare the dexmedetomidine group, the ibuprofen group, and the bupivacaine (control) group to see which one will be superior to the others.

Timeline

Start
2023-09-15
Primary completion
2024-03-01
Completion
2024-03-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 1 ug/kg Intrathecal
Subject Ibuprofen Small molecule 400 mg Intrathecal
Comparator Bupivacaine Other / unclassified 125 mg Intrathecal

Indications

No indication recorded.